Filter by: Subject
Now showing items 1-5 of 1
combination therapy (1) |
immune checkpoint inhibitors (1) |
nanomedicine (1) |
ovarian carcinomas (1) |
PARP inhibitors (1) |
combination therapy (1) |
immune checkpoint inhibitors (1) |
nanomedicine (1) |
ovarian carcinomas (1) |
PARP inhibitors (1) |